Peter Foley

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.

Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B Gordon, Peter Foley, Phoebe Rich, Carle Paul, Jerry Bagel, Elizabeth Colston, John Throup, Sudeep Kundu, Chitra Sekaran, Misti Linaberry, Subhashis Banerjee, Kim A Papp

Journal article  |  2023  |  J Am Acad Dermatol

BACKGROUND: Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, inhibits cytokine signaling in psoriasis ..

417 Dupilumab Significantly Improves Sleep Disturbance in Adults with Moderate-to-Severe Atopic Dermatitis: Results of the DUPISTAD study

JF Merola, AS Chiou, E During, A Costanzo, P Foley, M Ardeleanu, M Liu, Z Ozturk

Journal article  |  2022  |  Journal of Investigative Dermatology

Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis who responded at Week 16: Results from the BE BRIGHT open-label extension trial

Bruce Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard G Langley, Jonathan Barker, Maggie Wang, Veerle Vanvoorden, Balint Szilagyi, Valerie Ciaravino, Carle Paul

Journal article  |  2022  |  SKIN The Journal of Cutaneous Medicine

N/A

Innovative Widefield Volumetric Arc Radiation Therapy (VMAT) Approach to Simultaneously Treat Extensive Skin Field Cancerization (ESFC) In-Field Keratinocyte Carcinoma (KC) in Australian Patients: Report with 12 Month Follow-Up

AE Potter, C Baker, S Shumack, R Sinclair, WJ Curran, D Christie, BJ Wong, P Foley, PC O'Brien, L Spelman

Journal article  |  2022  |  International Journal of Radiation Oncology*Biology*Physics

Efficacité du baricinitib sur la perte de cheveux chez les patients atteints de pelade sévère : données issues de deux études contrôlées et randomisées de phase 3

S Vañó-Galván, TF Tsai, P Reygagne, H Petto, Y Dutronc, T Huete, F Durand, P Foley

Journal article  |  2022  |  Annales de Dermatologie et de Vénéréologie - FMC

Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting.

Claire Felmingham, Yan Pan, Yonatan Kok, John Kelly, Douglas Gin, Jennifer Nguyen, Michelle Goh, Alex Chamberlain, Amanda Oakley, Simon Tucker, William Berry, Mark Darling, Dale Jobson, Aaron Robinson, Sara de Menezes, Charlie Wang, Anneliese Willems, Catriona McLean, William Cranwell, Nikki Adler, et al.

Journal article  |  2022  |  J Am Acad Dermatol

Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting

Peter Foley, Yves A Kerdraon, John P Hogden, Stephen Shumack, Lynda Spelman, Deshan F Sebaratnam, Charles S Su, Constance H Katelaris

Journal article  |  2022  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

BACKGROUND/OBJECTIVES: Dupilumab-associated ocular surface disease (DAOSD) is of particular relevance in patients with atopic derm..

33028 Direct and indirect treatment effect of guselkumab on anxiety and depression in patients with psoriasis by adjusting for Psoriasis Area and Severity Index (PASI) – A mediation analysis

April Armstrong, Peter Foley, Yan Liu, Ya-Wen Yang, Megan Miller, Rachel E Teneralli, Anthony Bewley, Kenneth B Gordon, Chenglong Han

Journal article  |  2022  |  Journal of the American Academy of Dermatology

32953 Efficacy responses across disease severity and treatment history subgroups of patients with moderate to severe plaque psoriasis treated with guselkumab: Pooled results from VOYAGE 1&2 through 5 years

Kenneth B Gordon, Joseph F Merola, Peter Foley, Olivia Choi, Daphne Chan, Megan Miller, Yin You, Yaung-Kaung Shen, Ya-Wen Yang, Andrew Blauvelt

Journal article  |  2022  |  Journal of the American Academy of Dermatology

33991 Predictors of response to secukinumab in patients with moderate to severe plaque psoriasis with special area involvement in real-world clinical setting: A pooled analysis of prospective observational studies PROSPECT, SERENA, and REALIA

Diamant Thaci, Peter Foley, Craig Richardson, Yulin Shi, Juanzhi Fang, Matthias Augustin

Journal article  |  2022  |  Journal of the American Academy of Dermatology